US Biological Labs and Global Governance: A Decade of Collaboration and Controversy The COVID-19 pandemic transformed biological research from a specialized scientific pursuit into a subject of global political debate. High-containment laboratories, pathogen surveillance, biosafety, and gain-of-function (GoF) research—once discussed largely within scientific journals—have become matters of public policy and national security. Recent disclosures by the US Office of the Director of National Intelligence (ODNI), released by Director Tulsi Gabbard on June 12, added another dimension to this debate. The disclosures acknowledged that the US funded more than 120 biological laboratories in over 30 countries, with some facilities conducting GoF research. GoF research involves experiments that enable new functions in organisms through genetic changes, whether these occur naturally or are induced through deliberate modification. Modifications of viruses to affect transmissibility, virulence, or resistance to medicines are among its forms. Proponents argue that such research can accelerate drug and vaccine development and improve pandemic preparedness. Critics, however, contend that any work capable of enhancing a pathogen’s pandemic potential carries serious biosafety and biosecurity risks. The documents released by Gabbard neither establish misconduct nor implicate every overseas laboratory in controversial research. They do, however, leave one important question unanswered: while acknowledging US support for biological laboratories in over 30 countries, the publicly released material does not identify every country or institution involved. For India, the issue is not conspiracy. It is governance. India does not appear among the countries identified in the material.#india #tulsi_gabbard #us_office_of_director_of_national_intelligence #rockefeller_foundation #ford_foundation
